胰管和膽管支架的全球市場 - 市場規模（按細分市場）、份額、監管、報銷、治療、預測（截至 2033 年）

胰管和膽管支架市場主要由導致膽管和胰管阻塞的疾病所驅動。 ERCP 和 PTC 手術數量的增加正在推動市場，特別是需要支架置入和重複支架置入的手術。

本報告研究和分析了全球胰管支架/膽道支架市場，並提供了有關每個細分市場的市場規模、市場趨勢、競爭格局以及 COVID-19 影響的資訊。

市場模型的主要內容如下。

商用胰管支架與膽道支架的競爭格局不斷變化

• 對主要產業趨勢的考慮
• 按胰管支架/膽管支架市場細分的年收入和市場前景（2015-2033）
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域和國家層面的特定市場考量

• 按地區細分全球趨勢的特定市場定性資訊和國家/地區考慮因素
• 胰管支架/膽管支架市場SWOT分析
• 胰管支架/膽管支架市場競爭動態思考及趨勢

透過對醫療保健系統的真實、全面的了解來促進市場了解。 市場進入部分還提供有關報銷政策和監管環境的信息，使您能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技監理狀況

目標公司

• Boston Scientific Corp
• Becton Dickinson and Co
• Hellman & Friedman LLC
• ConMed Corp
• Cook Group Inc
• Hobbs Medical Inc
• Medtronic Plc
• Olympus Corp
• W. L. Gore & Associates Inc
• 其他

Abstract

Pancreatic and Biliary stent Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within General Surgery Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Pancreatic and Biliary Stents market for the year 2020 and beyond. Pancreatic and Biliary Stents are the tubular devices made either of plastic or metal. They are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These stents are also for preventing post- endoscopic retrograde cholangiopancreatography pancreatitis and to drain the gallbladder and pancreatic fluids. These stents are placed through two major procedures: Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC).

The Pancreatic and Biliary Stents market is mainly driven by the diseases resulting in the obstruction in bile or pancreatic ducts. Increase in the number of ERCP and PTC procedures has fuelled the market especially the procedures requiring stenting and recurrent stenting.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Pancreatic and Biliary Stents and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Pancreatic and Biliary Stents market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Pancreatic and Biliary stent market.
• Competitive dynamics insights and trends provided for Pancreatic and Biliary stent market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Becton Dickinson and Co, Hellman & Friedman LLC, ConMed Corp, Cook Group Inc, Hobbs Medical Inc, Medtronic Plc, Olympus Corp, W. L. Gore & Associates Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

CMO executives who must have deep understanding of the Pancreatic and Biliary Stents marketplace to make strategic planning and investment decisions.

Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

Understand the impact of COVID-19 on Pancreatic and Biliary Stents market.

Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving Pancreatic and Biliary Stents market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Pancreatic and Biliary Stents market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in the global and country-specific Pancreatic and Biliary Stents market from 2015-2033.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable